US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

8 deals · US$2.3bndisclosed · Clinical Trial Services · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Jan 2026 SubjectWell ––MergerAnnounced–Clinical Trial Services Stout (sell-side)Fairmount Partners (buy-side)
Apr 2026 Celerion H.I.G. Capital affiliateTHL PartnersAcquisitionAnnounced–Pharma Services+2 LazardKirkland & Ellis (buy-side)Paul, Weiss (buy-side)
Apr 2026 EpiVax –SV Health InvestorsAcquisitionAnnounced–Pharma Services+2 Morgan Lewis (buy-side)
Aug 2026 ZEPHYRx –a Leading Global CROAcquisitionCompleted–Healthcare Software+1 Morgan Lewis (sell-side)Edgemont Partners (sell-side)
Aug 2026 Precision Medicine Group BlackstoneMcKessonAcquisitionAnnounced2,250.0Clinical Trial Services+1 Debevoise & Plimpton (sell-side)Centerview Partners (sell-side)Davis Polk (buy-side)
Sep 2026 New Zealand Clinical Research Group (NZCR) –AdventAcquisitionAnnounced–Clinical Trial Services Cameron Partners (buy-side)
Sep 2026 Firma Data Services Firma Clinical ResearchEverest Clinical ResearchAsset saleCompleted–Clinical Trial Services+1 Edgemont Partners (sell-side)
Sep 2026 MLM Medical Labs –LabcorpAcquisitionAnnounced–Clinical Trial Services+1 William BlairEvercore (buy-side)Pierson Ferdinand (buy-side)Hogan Lovells Cadwalader (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built